Exchange: NASDAQ·Updated 07:34 PM EDT
News
all
press releases
GEHC or LMAT: Which Is the Better Value Stock Right Now?
GEHC vs. LMAT: Which Stock Is the Better Value Option?
Zacks
More News
LeMaitre Vascular (LMAT) Hit by Profit Taking
LeMaitre Vascular (LMAT) Hit by Profit Taking...
Yahoo! Finance: News
LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of -8.64% and -1.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates
Boston Scientific (BSX) delivered earnings and revenue surprises of +3.61% and +1.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Casey's & 3 More Stocks With Strong Interest Coverage to Buy Now
CASY, CLS, PNTG and LMAT stand out for strong interest coverage as borrowing costs rise, with solid sales/EPS growth estimates and big one-year gains.
Zacks
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why
LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.
Zacks
Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround
LeMaitre (LMAT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Zacks
LeMaitre Vascular Enters Oversold Territory
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important...
Nasdaq News: Markets
3 Reasons Growth Investors Will Love LeMaitre (LMAT)
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks
LeMaitre (LMAT) Upgraded to Buy: Here's Why
LeMaitre (LMAT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks

Advertisement|Remove ads.